MedTrace Logo

Does DHEA IVF Outcomes in Poor Responders?

NCT04066478 · Status: SUSPENDED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2022-06-23

No results posted yet for this study

Summary

This study is a RCT to examine whether DHEA is capable of improving results for poor responders to ovarian stimulation during IVF treatment

Conditions

  • Infertility, Female
  • Poor Response to Ovulation Induction

Interventions

DRUG

Dehydroepiandrosterone

75mg Dehydroepiandrosterone daily

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Homerton University Hospital NHS Foundation Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-08
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04066478 on ClinicalTrials.gov